Gyre Therapeutics (L9S.F) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.02
0
0.03
0.05

Details

Expected EPS
0.04919545605
Actual EPS
-0.017363
Surprise EPS
-0.07
Surprise Percent
+135.29%

Description

Gyre Therapeutics (L9S.F) has reported earnings of -0.017363 per share for Q1 2026.

0 Comments

Share your thoughts